Edwards Lifesciences Corp (EW) · Insider trading
What Edwards Lifesciences's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.
Bought, 12 months
$0
0 insiders, 0 trades
Sold, 12 months
$27.68M
9 insiders, 52% under a plan
Net, 12 months
−$27.68M
bought less sold
Latest filing
2026-09-14
filings read to 2026-10-19
Who traded, two years
| Insider | Bought | Sold | Trades | Last trade | Holds after |
|---|---|---|---|---|---|
| Bobo Donald e JrCVP,Strategy/Corp Development | – | $14.18M | 20 | 2026-05-27 | – |
| Zovighian Bernard JDirector, CEO | – | $9.19M | 12 | 2026-07-27 | – |
| Ullem Scott B.CVP, Chief Financial Officer | – | $7.96M | 13 | 2026-04-09 | 48,023 |
| Chopra DaveenCVP, TMTT, Surgical & IHFM | – | $3.64M | 7 | 2026-08-26 | 74,970 |
| Wood Larry LGlobal President TAVR & Surg | – | $3.02M | 3 | 2025-08-18 | 206,900 |
| Lippis Daniel J.CVP, TAVR | – | $1.53M | 20 | 2026-09-11 | 40,034 |
| Markowitz WayneCVP, JAPAC | – | $1.11M | 7 | 2026-08-26 | 20,294 |
| Stone Heisz LeslieDirector | – | $653,478 | 2 | 2025-12-12 | 30,948 |
| Loranger Steven RDirector | – | $438,574 | 1 | 2025-02-14 | 60,372 |
| Bruls AnnetteCVP, EMEACLA | – | $237,907 | 1 | 2026-08-28 | 17,984 |
| Dahl Andrew M.SVP, Corporate Controller | – | $98,390 | 2 | 2026-08-31 | 14,868 |
Open-market purchases and sales
Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.
| Date | Insider | Trade | Shares | Price | Value | Holds after | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-11 | Lippis Daniel J.CVP, TAVR | Saleplan | 619 | 87.51 | $54,169 | 40,034 | Form 4 |
| 2026-08-31 | Dahl Andrew M.SVP, Corporate Controller | Sale | 544 | 91.06 | $49,537 | 14,868 | Form 4 |
| 2026-08-28 | Bruls AnnetteCVP, EMEACLA | Sale | 2,644 | 89.98 | $237,907 | 17,984 | Form 4 |
| 2026-08-26 | Markowitz WayneCVP, JAPAC | Sale | 1,240 | 91.47 | $113,423 | 20,294 | Form 4 |
| 2026-08-26 | Chopra DaveenCVP, TMTT, Surgical & IHFM | Sale | 1,154 | 91.76 | $105,891 | 74,970 | Form 4 |
| 2026-08-26 | Chopra DaveenCVP, TMTT, Surgical & IHFM | Sale | 30,646 | 90.99 | $2.79M | 44,324 | Form 4 |
| 2026-08-11 | Lippis Daniel J.CVP, TAVR | Saleplan | 619 | 92.03 | $56,967 | 40,034 | Form 4 |
| 2026-07-30 | Markowitz WayneCVP, JAPAC | Sale | 146 | 86.03 | $12,587 | 21,534 | Form 4 |
| 2026-07-28 | Markowitz WayneCVP, JAPAC | Sale | 9,628 | 85.06 | $818,958 | 21,680 | Form 4 |
| 2026-07-27 | Zovighian Bernard JDirector, CEO | Saleindirect | 2,921 | 83.93 | $245,122 | 8,916 | Form 4 |
| 2026-07-10 | Lippis Daniel J.CVP, TAVR | Saleplan | 619 | 91.70 | $56,762 | 40,034 | Form 4 |
| 2026-06-30 | Lippis Daniel J.CVP, TAVR | Saleplan | 619 | 91.40 | $56,577 | 40,411 | Form 4 |
| 2026-06-17 | Zovighian Bernard JDirector, CEO | Saleplanindirect | 523 | 87.92 | $45,982 | 11,517 | Form 4 |
| 2026-05-29 | Dahl Andrew M.SVP, Corporate Controller | Sale | 568 | 86.08 | $48,853 | 15,334 | Form 4 |
| 2026-05-27 | Bobo Donald e JrCVP,Strategy/Corp Development | Saleindirect | 23,145 | 86.42 | $2.00M | 98,611 | Form 4 |
| 2026-05-22 | Chopra DaveenCVP, TMTT & Surgical | Sale | 1,500 | 84.60 | $126,900 | 44,324 | Form 4 |
| 2026-05-18 | Lippis Daniel J.CVP, TAVR | Saleplan | 620 | 81.14 | $50,307 | 40,411 | Form 4 |
| 2026-05-15 | Bobo Donald e JrCVP,Strategy/Corp Development | Sale | 9,968 | 82.07 | $818,074 | 22,798 | Form 4 |
| 2026-05-15 | Bobo Donald e JrCVP,Strategy/Corp Development | Saleindirect | 8,000 | 81.82 | $654,560 | 30,970 | Form 4 |
| 2026-05-12 | Zovighian Bernard JDirector, CEO | Saleplanindirect | 845 | 78.40 | $66,248 | 47,546 | Form 4 |
| 2026-05-12 | Zovighian Bernard JDirector, CEO | Saleplanindirect | 35,506 | 77.92 | $2.77M | 12,040 | Form 4 |
| 2026-05-11 | Markowitz WayneCVP, JAPAC | Sale | 593 | 79.73 | $47,280 | 21,680 | Form 4 |
| 2026-05-04 | Lippis Daniel J.CVP, TAVR | Saleplan | 1,019 | 83.98 | $85,576 | 33,682 | Form 4 |
| 2026-05-01 | Lippis Daniel J.CVP, TAVR | Saleplan | 19 | 83.99 | $1,596 | 34,934 | Form 4 |
| 2026-05-01 | Lippis Daniel J.CVP, TAVR | Saleplan | 1,000 | 82.99 | $82,990 | 33,934 | Form 4 |
| 2026-04-09 | Ullem Scott B.CVP, Chief Financial Officer | Saleplan | 4,676 | 80.50 | $376,418 | 48,023 | Form 4 |
| 2026-04-09 | Ullem Scott B.CVP, Chief Financial Officer | Saleplan | 8,324 | 79.79 | $664,172 | 39,699 | Form 4 |
| 2026-04-06 | Lippis Daniel J.CVP, TAVR | Saleplan | 1,019 | 80.98 | $82,519 | 33,934 | Form 4 |
| 2026-04-02 | Bobo Donald e JrCVP,Strategy/Corp Development | Saleplan | 4,676 | 80.59 | $376,839 | 39,270 | Form 4 |
| 2026-04-02 | Bobo Donald e JrCVP,Strategy/Corp Development | Saleplan | 18,004 | 80.05 | $1.44M | 21,266 | Form 4 |
| 2026-03-11 | Lippis Daniel J.CVP, TAVR | Saleplan | 1,019 | 85.38 | $87,002 | 33,934 | Form 4 |
| 2026-03-11 | Ullem Scott B.CVP, Chief Financial Officer | Saleplan | 5,099 | 84.46 | $430,662 | 47,600 | Form 4 |
| 2026-03-11 | Ullem Scott B.CVP, Chief Financial Officer | Saleplan | 7,901 | 85.21 | $673,244 | 39,699 | Form 4 |
| 2026-03-02 | Bobo Donald e JrCVP,Strategy/Corp Development | Saleplan | 11,340 | 85.93 | $974,446 | 21,266 | Form 4 |
| 2026-02-25 | Bobo Donald e JrCVP,Strategy/Corp Development | Sale | 24,000 | 83.84 | $2.01M | 21,266 | Form 4 |
| 2026-02-12 | Zovighian Bernard JDirector, CEO | Sale | 2,532 | 77.13 | $195,293 | 103,794 | Form 4 |
| 2026-02-12 | Zovighian Bernard JDirector, CEO | Sale | 19,898 | 76.61 | $1.52M | 83,896 | Form 4 |
| 2026-01-09 | Lippis Daniel J.CVP, TAVR | Saleplan | 1,019 | 85.70 | $87,328 | 22,002 | Form 4 |
| 2026-01-06 | Bobo Donald e JrCVP,Strategy/Corp Development | Saleplan | 2,632 | 84.62 | $222,720 | 40,578 | Form 4 |
| 2026-01-06 | Bobo Donald e JrCVP,Strategy/Corp Development | Saleplan | 8,708 | 85.98 | $748,714 | 31,870 | Form 4 |
48 more
| 2025-12-12 | Stone Heisz LeslieDirector | Sale | 2,615 | 83.41 | $218,117 | 30,948 | Form 4 |
| 2025-12-12 | Lippis Daniel J.CVP, JAPAC | Saleplan | 1,019 | 84.03 | $85,627 | 22,002 | Form 4 |
| 2025-12-12 | Bobo Donald e JrCVP,Strategy/Corp Development | Sale | 5,486 | 83.79 | $459,682 | 44,870 | Form 4 |
| 2025-12-12 | Bobo Donald e JrCVP,Strategy/Corp Development | Sale | 5,900 | 83.74 | $494,066 | 38,970 | Form 4 |
| 2025-12-11 | Chopra DaveenCVP, TMTT & Surgical | Sale | 2,000 | 84.38 | $168,760 | 32,201 | Form 4 |
| 2025-12-10 | Zovighian Bernard JDirector, CEO | Saleplanindirect | 3,863 | 83.45 | $322,367 | 8,597 | Form 4 |
| 2025-12-10 | Bobo Donald e JrCVP,Strategy/Corp Development | Saleplan | 11,340 | 83.83 | $950,632 | 50,356 | Form 4 |
| 2025-12-09 | Ullem Scott B.CVP, Chief Financial Officer | Saleplan | 7,700 | 84.47 | $650,419 | 39,898 | Form 4 |
| 2025-12-08 | Zovighian Bernard JDirector, CEO | Saleplan | 21,487 | 85.21 | $1.83M | 84,839 | Form 4 |
| 2025-12-08 | Markowitz WayneCVP, JAPAC | Sale | 583 | 86.01 | $50,144 | 17,563 | Form 4 |
| 2025-11-10 | Lippis Daniel J.CVP, JAPAC | Saleplan | 1,020 | 82.55 | $84,201 | 22,002 | Form 4 |
| 2025-11-10 | Ullem Scott B.CVP, Chief Financial Officer | Saleplan | 2,974 | 83.30 | $247,734 | 49,924 | Form 4 |
| 2025-11-10 | Ullem Scott B.CVP, Chief Financial Officer | Saleplan | 10,026 | 83.02 | $832,359 | 39,898 | Form 4 |
| 2025-08-25 | Chopra DaveenCVP, TMTT | Sale | 2,500 | 81.95 | $204,875 | 30,996 | Form 4 |
| 2025-08-18 | Wood Larry LGlobal President TAVR & Surg | Saleplan | 8,950 | 78.06 | $698,637 | 206,900 | Form 4 |
| 2025-07-28 | Lippis Daniel J.CVP, JAPAC | Sale | 4,114 | 79.46 | $326,898 | 22,002 | Form 4 |
| 2025-06-16 | Wood Larry LGlobal President TAVR & Surg | Saleplan | 8,950 | 75.23 | $673,308 | 206,900 | Form 4 |
| 2025-06-03 | Zovighian Bernard JDirector, CEO | Saleplanindirect | 967 | 77.32 | $74,768 | 8,597 | Form 4 |
| 2025-06-02 | Bobo Donald e JrCVP,Strategy/Corp Development | Saleplan | 2,570 | 77.40 | $198,918 | 50,356 | Form 4 |
| 2025-05-30 | Zovighian Bernard JDirector, CEO | Saleplanindirect | 16,099 | 77.21 | $1.24M | 9,564 | Form 4 |
| 2025-05-22 | Chopra DaveenCVP, TMTT | Sale | 1,500 | 75.08 | $112,620 | 33,496 | Form 4 |
| 2025-05-09 | Ullem Scott B.CVP, Chief Financial Officer | Saleplan | 11,250 | 74.40 | $837,000 | 41,098 | Form 4 |
| 2025-05-09 | Lippis Daniel J.CVP, JAPAC | Saleplan | 330 | 74.42 | $24,559 | 26,616 | Form 4 |
| 2025-05-07 | Markowitz WayneGM & SVP, Surgical | Sale | 268 | 75.08 | $20,121 | 9,299 | Form 4 |
| 2025-05-05 | Zovighian Bernard JDirector, CEO | Saleplan | 5,980 | 74.91 | $447,962 | 58,284 | Form 4 |
| 2025-04-14 | Bobo Donald e JrCVP,Strategy/Corp Development | Saleplan | 9,500 | 69.81 | $663,195 | 47,206 | Form 4 |
| 2025-04-08 | Lippis Daniel J.CVP, JAPAC | Saleplan | 300 | 70.61 | $21,183 | 22,863 | Form 4 |
| 2025-03-26 | Ullem Scott B.CVP, Chief Financial Officer | Saleplan | 11,250 | 70.87 | $797,288 | 30,387 | Form 4 |
| 2025-03-13 | Bobo Donald e JrCVP,Strategy/Corp Development | Saleplan | 9,500 | 67.96 | $645,620 | 46,936 | Form 4 |
| 2025-03-10 | Lippis Daniel J.CVP, JAPAC | Saleplan | 400 | 69.48 | $27,792 | 22,588 | Form 4 |
| 2025-03-10 | Zovighian Bernard JDirector, CEO | Saleplan | 6,164 | 69.51 | $428,460 | 59,083 | Form 4 |
| 2025-02-28 | Ullem Scott B.CVP, Chief Financial Officer | Saleplan | 3,490 | 71.38 | $249,116 | 38,147 | Form 4 |
| 2025-02-28 | Ullem Scott B.CVP, Chief Financial Officer | Saleplan | 7,760 | 70.52 | $547,235 | 30,387 | Form 4 |
| 2025-02-14 | Loranger Steven RDirector | Sale | 5,739 | 76.42 | $438,574 | 60,372 | Form 4 |
| 2025-02-13 | Stone Heisz LeslieDirector | Sale | 5,739 | 75.86 | $435,361 | 30,035 | Form 4 |
| 2025-02-13 | Lippis Daniel J.CVP, JAPAC | Saleplan | 500 | 76.34 | $38,170 | 23,189 | Form 4 |
| 2025-02-13 | Bobo Donald e JrCVP,Strategy/Corp Development | Saleplan | 100 | 76.26 | $7,626 | 53,336 | Form 4 |
| 2025-02-13 | Bobo Donald e JrCVP,Strategy/Corp Development | Saleplan | 6,400 | 75.74 | $484,736 | 46,936 | Form 4 |
| 2025-02-13 | Ullem Scott B.CVP, Chief Financial Officer | Saleplan | 11,250 | 75.76 | $852,300 | 30,561 | Form 4 |
| 2025-01-16 | Bobo Donald e JrCVP,Strategy/Corp Development | Saleplan | 5,000 | 68.75 | $343,750 | 46,936 | Form 4 |
| 2025-01-16 | Lippis Daniel J.CVP, JAPAC | Saleplan | 500 | 68.76 | $34,380 | 23,189 | Form 4 |
| 2024-12-16 | Lippis Daniel J.CVP, JAPAC | Saleplan | 2,500 | 74.08 | $185,200 | 23,189 | Form 4 |
| 2024-12-09 | Bobo Donald e JrCVP,Strategy/Corp Development | Saleplan | 5,000 | 71.75 | $358,750 | 46,936 | Form 4 |
| 2024-12-09 | Ullem Scott B.CVP, Chief Financial Officer | Saleplan | 11,250 | 71.68 | $806,400 | 30,561 | Form 4 |
| 2024-12-06 | Markowitz WayneGM & SVP, Surgical | Sale | 583 | 73.27 | $42,716 | 9,494 | Form 4 |
| 2024-12-06 | Chopra DaveenCVP, TMTT | Sale | 1,750 | 73.27 | $128,222 | 27,583 | Form 4 |
| 2024-11-13 | Bobo Donald e JrCVP,Strategy/Corp Development | Saleplan | 5,000 | 65.57 | $327,850 | 46,936 | Form 4 |
| 2024-11-05 | Wood Larry LGlobal President TAVR & Surg | Saleplan | 25,000 | 65.91 | $1.65M | 198,526 | Form 4 |
Grants, exercises and other transactions
Pay, tax and paperwork rather than a choice to trade at the market price. Two years.
70 × shares withheld for tax52 × option exercise43 × grant or award27 × gift
Show them
| Date | Insider | What | Shares | Price | Holds after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-14 | Markowitz WayneCVP, JAPAC | Shares withheld for tax F | −568 | 84.37 | 19,371 | Form 4 |
| 2026-09-13 | Dahl Andrew M.SVP, Corporate Controller | Shares withheld for tax F | −253 | 84.37 | 14,615 | Form 4 |
| 2026-09-11 | Markowitz WayneCVP, JAPAC | Shares withheld for tax F | −355 | 86.77 | 19,939 | Form 4 |
| 2026-09-11 | Lippis Daniel J.CVP, TAVR | Option exercise M | +619 | 72.68 | 40,653 | Form 4 |
| 2026-09-11 | Chopra DaveenCVP, TMTT, Surgical & IHFM | Shares withheld for tax F | −398 | 86.77 | 43,926 | Form 4 |
| 2026-08-26 | Chopra DaveenCVP, TMTT, Surgical & IHFM | Option exercise M | +31,800 | 72.68 | 76,124 | Form 4 |
| 2026-08-11 | Lippis Daniel J.CVP, TAVR | Option exercise M | +619 | 72.68 | 40,653 | Form 4 |
| 2026-07-28 | Markowitz WayneCVP, JAPAC | Option exercise M | +9,628 | 74.02 | 31,308 | Form 4 |
| 2026-07-27 | Zovighian Bernard JDirector, CEO | Gift G | −320 | – | 98,845 | Form 4 |
| 2026-07-27 | Zovighian Bernard JDirector, CEO | Gift G | +320 | – | 11,836 | Form 4 |
| 2026-07-11 | Bruls AnnetteCVP, EMEACLA | Shares withheld for tax F | −109 | 92.21 | 20,628 | Form 4 |
| 2026-07-10 | Lippis Daniel J.CVP, TAVR | Option exercise M | +619 | 72.68 | 40,653 | Form 4 |
| 2026-07-09 | Mistras TheodoraCVP, Chief Financial Officer | Grant or award A | +87,595 | – | 87,595 | Form 4 |
| 2026-07-09 | Mistras TheodoraCVP, Chief Financial Officer | Grant or award A | +12,325 | – | 99,920 | Form 4 |
| 2026-07-07 | Lippis Daniel J.CVP, TAVR | Shares withheld for tax F | −377 | 95.18 | 40,034 | Form 4 |
| 2026-06-30 | Lippis Daniel J.CVP, TAVR | Option exercise M | +619 | 72.68 | 41,030 | Form 4 |
| 2026-05-18 | Lippis Daniel J.CVP, TAVR | Option exercise M | +620 | 72.68 | 41,031 | Form 4 |
| 2026-05-12 | Zovighian Bernard JDirector, CEO | Gift G | −26,640 | – | 99,165 | Form 4 |
| 2026-05-12 | Zovighian Bernard JDirector, CEO | Gift G | +26,640 | – | 48,391 | Form 4 |
| 2026-05-11 | Chopra DaveenCVP, TMTT & Surgical | Option exercise M | +13,583 | – | 53,362 | Form 4 |
| 2026-05-11 | Chopra DaveenCVP, TMTT & Surgical | Shares withheld for tax F | −7,538 | 79.96 | 45,824 | Form 4 |
| 2026-05-11 | Bobo Donald e JrCVP,Strategy/Corp Development | Option exercise M | +13,457 | – | 40,235 | Form 4 |
| 2026-05-11 | Bobo Donald e JrCVP,Strategy/Corp Development | Shares withheld for tax F | −7,469 | 79.96 | 32,766 | Form 4 |
| 2026-05-11 | Zovighian Bernard JDirector, CEO | Option exercise M | +47,207 | – | 157,492 | Form 4 |
| 2026-05-11 | Zovighian Bernard JDirector, CEO | Shares withheld for tax F | −26,198 | 79.96 | 125,805 | Form 4 |
| 2026-05-11 | Lippis Daniel J.CVP, TAVR | Shares withheld for tax F | −362 | 79.96 | 40,411 | Form 4 |
| 2026-05-11 | Zovighian Bernard JDirector, CEO | Gift G | −5,489 | – | 104,796 | Form 4 |
| 2026-05-11 | Zovighian Bernard JDirector, CEO | Gift G | +5,489 | – | 21,751 | Form 4 |
| 2026-05-11 | Ullem Scott B.CVP, Chief Financial Officer | Option exercise M | +19,830 | – | 57,744 | Form 4 |
| 2026-05-11 | Ullem Scott B.CVP, Chief Financial Officer | Shares withheld for tax F | −11,004 | 79.96 | 46,740 | Form 4 |
| 2026-05-08 | Zovighian Bernard JDirector, CEO | Gift G | −4,222 | – | 115,683 | Form 4 |
| 2026-05-08 | Zovighian Bernard JDirector, CEO | Shares withheld for tax F | −5,398 | 82.76 | 110,285 | Form 4 |
| 2026-05-08 | Zovighian Bernard JDirector, CEO | Gift G | +4,222 | – | 16,262 | Form 4 |
| 2026-05-08 | Markowitz WayneCVP, JAPAC | Shares withheld for tax F | −226 | 82.76 | 22,273 | Form 4 |
| 2026-05-08 | Bruls AnnetteCVP, EMEACLA | Shares withheld for tax F | −84 | 82.76 | 20,737 | Form 4 |
| 2026-05-08 | Chopra DaveenCVP, TMTT & Surgical | Shares withheld for tax F | −1,141 | 82.76 | 39,779 | Form 4 |
| 2026-05-08 | Dahl Andrew M.SVP, Corporate Controller | Shares withheld for tax F | −289 | 82.76 | 15,902 | Form 4 |
| 2026-05-08 | Lippis Daniel J.CVP, TAVR | Shares withheld for tax F | −450 | 82.76 | 40,773 | Form 4 |
| 2026-05-08 | Davis Leslie C.Director | Grant or award A | +3,251 | – | 9,834 | Form 4 |
| 2026-05-08 | Ullem Scott B.CVP, Chief Financial Officer | Shares withheld for tax F | −1,661 | 82.76 | 37,914 | Form 4 |
| 2026-05-08 | Bobo Donald e JrCVP,Strategy/Corp Development | Shares withheld for tax F | −1,038 | 82.76 | 26,778 | Form 4 |
| 2026-05-08 | Feinberg David TDirector | Grant or award A | +3,251 | – | 9,087 | Form 4 |
| 2026-05-08 | Gallahue KieranDirector | Grant or award A | +3,251 | – | 3,251 | Form 4 |
| 2026-05-08 | Gallahue KieranDirector | Grant or award A | +1,064 | – | 4,315 | Form 4 |
| 2026-05-08 | Stone Heisz LeslieDirector | Grant or award A | +3,251 | – | 34,199 | Form 4 |
| 2026-05-08 | Laviolette Paul ADirector | Grant or award A | +3,251 | – | 17,552 | Form 4 |
| 2026-05-08 | Loranger Steven RDirector | Grant or award A | +3,251 | – | 7,933 | Form 4 |
| 2026-05-08 | Loranger Steven RDirector | Grant or award A | +1,064 | – | 8,997 | Form 4 |
| 2026-05-08 | Sequeira RamonaDirector | Grant or award A | +3,251 | – | 6,779 | Form 4 |
| 2026-05-08 | Valeriani Nicholas JDirector | Grant or award A | +5,127 | – | 84,423 | Form 4 |
| 2026-05-07 | Zovighian Bernard JDirector, CEO | Grant or award A | +43,800 | – | 124,058 | Form 4 |
| 2026-05-07 | Zovighian Bernard JDirector, CEO | Shares withheld for tax F | −4,153 | 83.20 | 119,905 | Form 4 |
| 2026-05-07 | Markowitz WayneCVP, JAPAC | Grant or award A | +5,200 | – | 22,763 | Form 4 |
| 2026-05-07 | Markowitz WayneCVP, JAPAC | Shares withheld for tax F | −264 | 83.20 | 22,499 | Form 4 |
| 2026-05-07 | Bruls AnnetteCVP, EMEACLA | Grant or award A | +6,650 | – | 20,821 | Form 4 |
| 2026-05-07 | Chopra DaveenCVP, TMTT & Surgical | Grant or award A | +9,675 | – | 41,594 | Form 4 |
| 2026-05-07 | Chopra DaveenCVP, TMTT & Surgical | Shares withheld for tax F | −674 | 83.20 | 40,920 | Form 4 |
| 2026-05-07 | Dahl Andrew M.SVP, Corporate Controller | Grant or award A | +3,985 | – | 13,171 | Form 4 |
| 2026-05-07 | Dahl Andrew M.SVP, Corporate Controller | Grant or award A | +3,020 | – | 16,191 | Form 4 |
| 2026-05-07 | Lippis Daniel J.CVP, TAVR | Grant or award A | +7,850 | – | 41,532 | Form 4 |
| 2026-05-07 | Lippis Daniel J.CVP, TAVR | Shares withheld for tax F | −309 | 83.20 | 41,223 | Form 4 |
| 2026-05-07 | Ullem Scott B.CVP, Chief Financial Officer | Shares withheld for tax F | −1,373 | 83.20 | 39,575 | Form 4 |
| 2026-05-07 | Bobo Donald e JrCVP,Strategy/Corp Development | Grant or award A | +7,850 | – | 28,647 | Form 4 |
| 2026-05-07 | Bobo Donald e JrCVP,Strategy/Corp Development | Shares withheld for tax F | −831 | 83.20 | 27,816 | Form 4 |
| 2026-05-05 | Zovighian Bernard JDirector, CEO | Gift G | −523 | – | 80,258 | Form 4 |
| 2026-05-05 | Zovighian Bernard JDirector, CEO | Gift G | +523 | – | 12,040 | Form 4 |
| 2026-05-05 | Ullem Scott B.CVP, Chief Financial Officer | Option exercise M | +13,000 | 59.26 | 52,079 | Form 4 |
| 2026-05-05 | Ullem Scott B.CVP, Chief Financial Officer | Shares withheld for tax F | −11,131 | 82.91 | 40,948 | Form 4 |
| 2026-05-04 | Lippis Daniel J.CVP, TAVR | Option exercise M | +1,019 | 59.26 | 34,701 | Form 4 |
| 2026-05-03 | Zovighian Bernard JDirector, CEO | Shares withheld for tax F | −515 | 83.98 | 80,781 | Form 4 |
| 2026-05-03 | Ullem Scott B.CVP, Chief Financial Officer | Shares withheld for tax F | −620 | 83.98 | 39,079 | Form 4 |
| 2026-05-03 | Bobo Donald e JrCVP,Strategy/Corp Development | Shares withheld for tax F | −469 | 83.98 | 20,797 | Form 4 |
| 2026-05-03 | Chopra DaveenCVP, TMTT & Surgical | Shares withheld for tax F | −282 | 83.98 | 31,919 | Form 4 |
| 2026-05-03 | Lippis Daniel J.CVP, TAVR | Shares withheld for tax F | −252 | 83.98 | 33,682 | Form 4 |
| 2026-05-01 | Lippis Daniel J.CVP, TAVR | Option exercise M | +1,019 | 59.26 | 34,953 | Form 4 |
| 2026-04-09 | Ullem Scott B.CVP, Chief Financial Officer | Option exercise M | +13,000 | 59.26 | 52,699 | Form 4 |
| 2026-04-06 | Lippis Daniel J.CVP, TAVR | Option exercise M | +1,019 | 59.26 | 34,953 | Form 4 |
| 2026-04-02 | Bobo Donald e JrCVP,Strategy/Corp Development | Option exercise M | +22,680 | 59.26 | 43,946 | Form 4 |
| 2026-03-11 | Lippis Daniel J.CVP, TAVR | Option exercise M | +1,019 | 59.26 | 34,953 | Form 4 |
| 2026-03-11 | Ullem Scott B.CVP, Chief Financial Officer | Option exercise M | +13,000 | 59.26 | 52,699 | Form 4 |
| 2026-03-02 | Bobo Donald e JrCVP,Strategy/Corp Development | Option exercise M | +11,340 | 59.26 | 32,606 | Form 4 |
| 2026-02-22 | Dahl Andrew M.SVP, Corporate Controller | Shares withheld for tax F | −176 | 79.78 | 9,089 | Form 4 |
| 2026-02-22 | Lippis Daniel J.CVP, TAVR | Shares withheld for tax F | −432 | 79.78 | 33,934 | Form 4 |
| 2026-02-17 | Lippis Daniel J.CVP, TAVR | Shares withheld for tax F | −198 | 75.87 | 34,366 | Form 4 |
| 2026-02-16 | Lippis Daniel J.CVP, TAVR | Shares withheld for tax F | −258 | 75.87 | 34,564 | Form 4 |
| 2026-02-16 | Ullem Scott B.CVP, Chief Financial Officer | Shares withheld for tax F | −199 | 75.87 | 39,699 | Form 4 |
| 2026-02-13 | Zovighian Bernard JDirector, CEO | Gift G | −2,920 | – | 80,976 | Form 4 |
| 2026-02-13 | Zovighian Bernard JDirector, CEO | Gift G | +2,920 | – | 11,517 | Form 4 |
| 2026-02-12 | Lippis Daniel J.CVP, TAVR | Grant or award A | +12,820 | – | 34,822 | Form 4 |
| 2026-02-12 | Zovighian Bernard JDirector, CEO | Option exercise M | +25,350 | 59.26 | 106,326 | Form 4 |
| 2026-01-09 | Lippis Daniel J.CVP, TAVR | Option exercise M | +1,019 | 59.26 | 23,021 | Form 4 |
| 2026-01-06 | Bobo Donald e JrCVP,Strategy/Corp Development | Option exercise M | +11,340 | 59.26 | 43,210 | Form 4 |
| 2025-12-12 | Lippis Daniel J.CVP, JAPAC | Option exercise M | +1,019 | 59.26 | 23,021 | Form 4 |
| 2025-12-12 | Bobo Donald e JrCVP,Strategy/Corp Development | Gift G | −7,100 | – | 31,870 | Form 4 |
| 2025-12-10 | Bobo Donald e JrCVP,Strategy/Corp Development | Option exercise M | +11,340 | 59.26 | 61,696 | Form 4 |
| 2025-12-09 | Zovighian Bernard JDirector, CEO | Gift G | −3,863 | – | 80,976 | Form 4 |
| 2025-12-09 | Zovighian Bernard JDirector, CEO | Gift G | +3,863 | – | 12,460 | Form 4 |
| 2025-12-09 | Ullem Scott B.CVP, Chief Financial Officer | Option exercise M | +7,700 | 59.26 | 47,598 | Form 4 |
| 2025-12-08 | Zovighian Bernard JDirector, CEO | Option exercise M | +25,350 | 59.26 | 106,326 | Form 4 |
| 2025-11-13 | Dahl Andrew M.SVP, Corporate Controller | Grant or award A | +1,160 | – | 9,183 | Form 4 |
| 2025-11-10 | Lippis Daniel J.CVP, JAPAC | Option exercise M | +1,020 | 59.26 | 23,022 | Form 4 |
| 2025-11-10 | Ullem Scott B.CVP, Chief Financial Officer | Option exercise M | +13,000 | 59.26 | 52,898 | Form 4 |
| 2025-09-14 | Markowitz WayneCVP, JAPAC | Shares withheld for tax F | −650 | 77.57 | 18,146 | Form 4 |
| 2025-09-13 | Dahl Andrew M.SVP, Corporate Controller | Shares withheld for tax F | −262 | 77.57 | 7,927 | Form 4 |
| 2025-09-11 | Markowitz WayneCVP, JAPAC | Grant or award A | +6,410 | – | 18,796 | Form 4 |
| 2025-09-11 | Chopra DaveenCVP, TMTT & Surgical | Grant or award A | +3,205 | – | 34,201 | Form 4 |
| 2025-08-18 | Wood Larry LGlobal President TAVR & Surg | Option exercise M | +8,950 | 59.26 | 215,850 | Form 4 |
| 2025-07-11 | Bruls AnnetteCVP, EMEACLA | Shares withheld for tax F | −109 | 78.80 | 14,171 | Form 4 |
| 2025-07-07 | Lippis Daniel J.CVP, JAPAC | Shares withheld for tax F | −333 | 76.79 | 26,116 | Form 4 |
| 2025-06-16 | Wood Larry LGlobal President TAVR & Surg | Option exercise M | +8,950 | 59.26 | 215,850 | Form 4 |
| 2025-05-16 | Zovighian Bernard JDirector, CEO | Gift G | −5,816 | – | 80,976 | Form 4 |
| 2025-05-16 | Zovighian Bernard JDirector, CEO | Gift G | +5,816 | – | 25,663 | Form 4 |
| 2025-05-13 | Zovighian Bernard JDirector, CEO | Gift G | −2,771 | – | 86,792 | Form 4 |
| 2025-05-13 | Zovighian Bernard JDirector, CEO | Gift G | +2,771 | – | 19,847 | Form 4 |
| 2025-05-11 | Zovighian Bernard JDirector, CEO | Shares withheld for tax F | −2,860 | 73.68 | 89,563 | Form 4 |
| 2025-05-11 | Wood Larry LGlobal President TAVR & Surg | Shares withheld for tax F | −988 | 73.68 | 206,900 | Form 4 |
| 2025-05-11 | Ullem Scott B.CVP, Chief Financial Officer | Shares withheld for tax F | −1,200 | 73.68 | 39,898 | Form 4 |
| 2025-05-11 | Lippis Daniel J.CVP, JAPAC | Shares withheld for tax F | −271 | 73.68 | 26,345 | Form 4 |
| 2025-05-11 | Chopra DaveenCVP, TMTT | Shares withheld for tax F | −580 | 73.68 | 34,996 | Form 4 |
| 2025-05-11 | Bobo Donald e JrCVP,Strategy/Corp Development | Shares withheld for tax F | −816 | 73.68 | 52,926 | Form 4 |
| 2025-05-09 | Ullem Scott B.CVP, Chief Financial Officer | Option exercise M | +11,250 | 45.28 | 52,348 | Form 4 |
| 2025-05-09 | Lippis Daniel J.CVP, JAPAC | Option exercise M | +330 | 45.28 | 26,946 | Form 4 |
| 2025-05-09 | Davis Leslie C.Director | Grant or award A | +3,528 | – | 6,583 | Form 4 |
| 2025-05-09 | Feinberg David TDirector | Grant or award A | +3,528 | – | 5,836 | Form 4 |
| 2025-05-09 | Gallahue KieranDirector | Grant or award A | +3,528 | – | 3,528 | Form 4 |
| 2025-05-09 | Gallahue KieranDirector | Grant or award A | +1,154 | – | 4,682 | Form 4 |
| 2025-05-09 | Stone Heisz LeslieDirector | Grant or award A | +3,528 | – | 33,563 | Form 4 |
| 2025-05-09 | Laviolette Paul ADirector | Grant or award A | +3,528 | – | 14,301 | Form 4 |
| 2025-05-09 | Loranger Steven RDirector | Grant or award A | +3,528 | – | 63,900 | Form 4 |
| 2025-05-09 | Loranger Steven RDirector | Grant or award A | +1,154 | – | 65,054 | Form 4 |
| 2025-05-09 | Sequeira RamonaDirector | Grant or award A | +3,528 | – | 11,686 | Form 4 |
| 2025-05-09 | Valeriani Nicholas JDirector | Grant or award A | +5,564 | – | 79,296 | Form 4 |
| 2025-05-08 | Bobo Donald e JrCVP,Strategy/Corp Development | Grant or award A | +8,375 | – | 53,742 | Form 4 |
| 2025-05-08 | Wood Larry LGlobal President TAVR & Surg | Grant or award A | +11,050 | – | 207,888 | Form 4 |
| 2025-05-08 | Zovighian Bernard JDirector, CEO | Grant or award A | +43,550 | – | 96,545 | Form 4 |
| 2025-05-08 | Zovighian Bernard JDirector, CEO | Gift G | −4,122 | – | 92,423 | Form 4 |
| 2025-05-08 | Zovighian Bernard JDirector, CEO | Gift G | +4,122 | – | 17,076 | Form 4 |
| 2025-05-08 | Ullem Scott B.CVP, Chief Financial Officer | Grant or award A | +13,400 | – | 41,098 | Form 4 |
| 2025-05-08 | Chopra DaveenCVP, TMTT | Grant or award A | +9,200 | – | 35,576 | Form 4 |
| 2025-05-08 | Markowitz WayneGM & SVP, Surgical | Grant or award A | +3,350 | – | 12,349 | Form 4 |
| 2025-05-08 | Dahl Andrew M.SVP, Corporate Controller | Grant or award A | +3,335 | – | 8,107 | Form 4 |
| 2025-05-08 | Lippis Daniel J.CVP, JAPAC | Grant or award A | +4,225 | – | 26,616 | Form 4 |
| 2025-05-08 | Bruls AnnetteCVP, EMEACLA | Grant or award A | +6,200 | – | 14,280 | Form 4 |
| 2025-05-07 | Bobo Donald e JrCVP,Strategy/Corp Development | Shares withheld for tax F | −851 | 74.92 | 45,367 | Form 4 |
| 2025-05-07 | Wood Larry LGlobal President TAVR & Surg | Shares withheld for tax F | −819 | 74.92 | 196,838 | Form 4 |
| 2025-05-07 | Zovighian Bernard JDirector, CEO | Shares withheld for tax F | −4,253 | 74.92 | 52,995 | Form 4 |
| 2025-05-07 | Ullem Scott B.CVP, Chief Financial Officer | Shares withheld for tax F | −1,406 | 74.92 | 27,698 | Form 4 |
| 2025-05-07 | Chopra DaveenCVP, TMTT | Shares withheld for tax F | −627 | 74.92 | 26,376 | Form 4 |
| 2025-05-07 | Markowitz WayneGM & SVP, Surgical | Shares withheld for tax F | −300 | 74.92 | 8,999 | Form 4 |
| 2025-05-06 | Zovighian Bernard JDirector, CEO | Gift G | −1,036 | – | 57,248 | Form 4 |
| 2025-05-06 | Zovighian Bernard JDirector, CEO | Gift G | +1,036 | – | 12,954 | Form 4 |
| 2025-05-05 | Zovighian Bernard JDirector, CEO | Option exercise M | +7,462 | 45.28 | 65,746 | Form 4 |
| 2025-05-05 | Zovighian Bernard JDirector, CEO | Gift G | −1,482 | – | 64,264 | Form 4 |
| 2025-05-05 | Zovighian Bernard JDirector, CEO | Gift G | +1,482 | – | 11,918 | Form 4 |
| 2025-05-04 | Zovighian Bernard JDirector, CEO | Shares withheld for tax F | −543 | 75.65 | 58,284 | Form 4 |
| 2025-05-04 | Ullem Scott B.CVP, Chief Financial Officer | Shares withheld for tax F | −648 | 75.65 | 29,104 | Form 4 |
| 2025-05-04 | Bobo Donald e JrCVP,Strategy/Corp Development | Shares withheld for tax F | −508 | 75.65 | 46,218 | Form 4 |
| 2025-05-04 | Chopra DaveenCVP, TMTT | Shares withheld for tax F | −289 | 75.65 | 27,003 | Form 4 |
| 2025-05-04 | Wood Larry LGlobal President TAVR & Surg | Shares withheld for tax F | −410 | 75.65 | 197,657 | Form 4 |
| 2025-05-04 | Lippis Daniel J.CVP, JAPAC | Shares withheld for tax F | −247 | 75.65 | 22,391 | Form 4 |
| 2025-05-03 | Zovighian Bernard JDirector, CEO | Shares withheld for tax F | −527 | 75.65 | 58,827 | Form 4 |
| 2025-05-03 | Ullem Scott B.CVP, Chief Financial Officer | Shares withheld for tax F | −635 | 75.65 | 29,752 | Form 4 |
| 2025-05-03 | Bobo Donald e JrCVP,Strategy/Corp Development | Shares withheld for tax F | −480 | 75.65 | 46,726 | Form 4 |
| 2025-05-03 | Chopra DaveenCVP, TMTT | Shares withheld for tax F | −291 | 75.65 | 27,292 | Form 4 |
| 2025-05-03 | Wood Larry LGlobal President TAVR & Surg | Shares withheld for tax F | −396 | 75.65 | 198,067 | Form 4 |
| 2025-05-03 | Lippis Daniel J.CVP, JAPAC | Shares withheld for tax F | −225 | 75.65 | 22,638 | Form 4 |
| 2025-04-14 | Bobo Donald e JrCVP,Strategy/Corp Development | Option exercise M | +9,500 | 45.28 | 56,706 | Form 4 |
| 2025-04-08 | Lippis Daniel J.CVP, JAPAC | Option exercise M | +300 | 45.28 | 23,163 | Form 4 |
| 2025-03-26 | Ullem Scott B.CVP, Chief Financial Officer | Option exercise M | +11,250 | 45.28 | 41,637 | Form 4 |
| 2025-03-13 | Bobo Donald e JrCVP,Strategy/Corp Development | Option exercise M | +9,500 | 45.28 | 56,436 | Form 4 |
| 2025-03-10 | Lippis Daniel J.CVP, JAPAC | Option exercise M | +400 | 45.28 | 22,988 | Form 4 |
| 2025-03-10 | Zovighian Bernard JDirector, CEO | Option exercise M | +7,463 | 45.28 | 66,546 | Form 4 |
| 2025-03-10 | Zovighian Bernard JDirector, CEO | Gift G | −1,299 | – | 65,247 | Form 4 |
| 2025-03-10 | Zovighian Bernard JDirector, CEO | Gift G | +1,299 | – | 10,436 | Form 4 |
| 2025-02-28 | Ullem Scott B.CVP, Chief Financial Officer | Option exercise M | +11,250 | 45.28 | 41,637 | Form 4 |
| 2025-02-22 | Dahl Andrew M.SVP, Corporate Controller | Shares withheld for tax F | −176 | 73.30 | 4,684 | Form 4 |
| 2025-02-18 | Lippis Daniel J.CVP, JAPAC | Shares withheld for tax F | −222 | 76.19 | 22,588 | Form 4 |
| 2025-02-17 | Lippis Daniel J.CVP, JAPAC | Shares withheld for tax F | −165 | 76.19 | 22,810 | Form 4 |
| 2025-02-16 | Wood Larry LGlobal President TAVR & Surg | Shares withheld for tax F | −333 | 76.19 | 198,193 | Form 4 |
| 2025-02-16 | Ullem Scott B.CVP, Chief Financial Officer | Shares withheld for tax F | −174 | 76.19 | 30,387 | Form 4 |
| 2025-02-16 | Lippis Daniel J.CVP, JAPAC | Shares withheld for tax F | −214 | 76.19 | 22,975 | Form 4 |
| 2025-02-14 | Loranger Steven RDirector | Option exercise M | +5,739 | 45.32 | 66,111 | Form 4 |
| 2025-02-13 | Stone Heisz LeslieDirector | Option exercise M | +5,739 | 45.32 | 35,774 | Form 4 |
| 2025-02-13 | Lippis Daniel J.CVP, JAPAC | Option exercise M | +500 | 45.28 | 23,689 | Form 4 |
| 2025-02-13 | Bobo Donald e JrCVP,Strategy/Corp Development | Option exercise M | +6,500 | 45.28 | 53,436 | Form 4 |
| 2025-02-13 | Ullem Scott B.CVP, Chief Financial Officer | Option exercise M | +11,250 | 45.28 | 41,811 | Form 4 |
| 2025-01-16 | Bobo Donald e JrCVP,Strategy/Corp Development | Option exercise M | +5,000 | 45.28 | 51,936 | Form 4 |
| 2025-01-16 | Lippis Daniel J.CVP, JAPAC | Option exercise M | +500 | 45.28 | 23,689 | Form 4 |
| 2024-12-16 | Lippis Daniel J.CVP, JAPAC | Option exercise M | +2,500 | 45.28 | 25,689 | Form 4 |
| 2024-12-09 | Bobo Donald e JrCVP,Strategy/Corp Development | Option exercise M | +5,000 | 45.28 | 51,936 | Form 4 |
| 2024-12-09 | Ullem Scott B.CVP, Chief Financial Officer | Option exercise M | +11,250 | 45.28 | 41,811 | Form 4 |
| 2024-11-13 | Bobo Donald e JrCVP,Strategy/Corp Development | Option exercise M | +5,000 | 45.28 | 51,936 | Form 4 |
How to read it
- Buy, sale
- Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
- Plan
- A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
- Holds after
- The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
- Value
- Shares times the price the form reports, which is often an average over several fills on the day.
Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.